Improvement seen in headache frequency, intensity, pill count, disability assessments
WEDNESDAY, May 6, 2020 (HealthDay News) — Yoga plus medical care is better than medical therapy alone for the treatment of episodic migraines, according to a study published online May 6 in Neurology.
Anand Kumar, M.D., D.M., from the All India Institute of Medical Sciences in New Delhi, and colleagues randomly assigned 160 patients (aged 18 to 50 years) with episodic migraine to conventional medical care alone or a three-month yoga intervention plus medical care.
The researchers found that compared with medical therapy alone, the yoga group showed a significant mean reduction in headache frequency (delta difference, 3.53; 95 percent confidence interval [CI], 2.52 to 4.54; P < 0.0001), headache intensity (delta difference, 1.31; 95 percent CI, 0.60 to 2.01; P = 0.0004), Headache Impact Test score (delta difference, 8.0; 95 percent CI, 4.78 to 11.22; P < 0.0001), Migraine Disability Assessment score (delta difference, 7.85; 95 percent CI, 4.98 to 10.97; P < 0.0001), and pill count (delta difference, 2.28; 95 percent CI, 1.06 to 3.51; P < 0.0003).
“Our results show that yoga can reduce not just the pain, but also the treatment cost of migraines,” a coauthor said in a statement. “That can be a real game changer, especially for people who struggle to afford their medication. Medications are usually prescribed first, and some can be expensive.”
Abstract/Full Text (subscription or payment may be required)
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus
Recommendations Updated for Management of Anemia in CKD
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
More Advanced CKM Syndrome Linked to Worse Cardiovascular Health
Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML